A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse.
Noga Shem-Tov,Noga Shem-Tov,Francesco Saraceni,Francesco Saraceni,Ivetta Danylesko,Ivetta Danylesko,Roni Shouval,Roni Shouval,Ronit Yerushalmi,Ronit Yerushalmi,Arnon Nagler,Arnon Nagler,Avichai Shimoni,Avichai Shimoni +13 more
TL;DR: iEMR occurs later than BMR and more commonly in patients with chronic GVHD, suggesting less effective graft-versus-leukemia effect in extramedullary sites and long-term survival is feasible with aggressive treatment.
Journal ArticleDOI
Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients
TL;DR: Long-term follow-up of antibodies to HBsAg in humans who received allogeneic bone marrow transplantation from donors immunized withHBsAg suggest that adoptive transfer of immunity to HBV is a useful method for providing long-lasting protection for BM recipients.
Journal ArticleDOI
Tissue regeneration potential in human umbilical cord blood
TL;DR: This review focusses on current studies using human CB-derived cells for regenerative medicine and the elucidation of non-haematopoietic applications for CB will facilitate the development of pioneering relevant cell therapy approaches.
Journal ArticleDOI
Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan elimination.
Shlomo Almog,Shlomo Almog,Daniel Kurnik,Daniel Kurnik,Avichai Shimoni,Avichai Shimoni,Ronen Loebstein,Ronen Loebstein,Eyal Hassoun,Asher Gopher,Hillel Halkin,Hillel Halkin,Arnon Nagler,Arnon Nagler +13 more
TL;DR: The data indicate that Bu PK parameters are linear, stable, and predictable in different i.v. protocols and are unaffected by coadministration of fludarabine.
Journal ArticleDOI
Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone.
TL;DR: The effect of halofuginone-containing cream was applied on the tight-skin mouse (Tsk) and skin biopsies were taken for collagen staining by sirius red and for collagen α1(I) gene expression by in situ hybridization.